ClinicalTrials.govclosed

Dose Escalation of Bivatuzumab Mertansine in Female Patients With CD44v6 Positive Recurrent or Metastatic Breast Cancer

ClinicalTrials.gov study NCT02254031. IPD Sharing: NO. Countries: 0. Publications: 0.

ShareScore

16/100

Overall dataset sharing score

Score breakdown

These five areas show where the dataset supports — or may limit — practical reuse.

Stewardship: 8
Harmonization: 4
Access: 0
Reuse readiness: 0
Engagement: 4

Topics

clinical trial NIH ClinicalTrials.gov

Dataset details

Repository: ClinicalTrials.gov
Published: February 11, 2026
License: IPD-NO
DOI: clinicaltrials.gov/NCT02254031

Scored with release 0.9.0

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CV How the NIH biosketch works